Abstract:Despite medical therapeutic advances,congestive heart failure(CHF) which is the common ultimate consequence of many primary cardiovascular diseases and leads to loss of functional myocytes and structural integrity,remains a major and growing public health problem.Although orthotopic heart transplantation is the gold standard,inadequate donor availability has stimulated efforts to manage terminally injured myocardium by other innovative methods.There is now growing evidence that one therapeutic option could be cellular cardiomyoplasty(CCM).Cellular cardiomyoplasty refers to the implantation of different kinds of cells besides autologous cardiomyocytes into the myocardium to reinforce its structure and function.Recent progress in the cardiotypic differentiation of embryonic and somatic stem cells opens novel prospects for the treatment of cardiovascular disorders.Besides,several other different cell types,ranging from autologous skeletal myoblasts to endothelial progenitor cells and so on,have been successfully propagated within damaged heart and shown to improve myocardial performance.Here we will overview the different types of cells used for cardiac cell transplantation.

Development of Study on Cellular Cardiomyoplasty